Johnson & Johnson stock: Bernstein lifts target for Johnson & Johnson stock from USD 261 to USD 270

Published on 10/19/2026 at 15:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sales reached USD 25.40 billion in the third quarter. Johnson & Johnson stock costs EUR 227.08 on October 19, 2026, minus 0.51 percent versus Xetra close.

Analyst target and market setting

Bernstein raised its Johnson & Johnson target from USD 261 to USD 270 on October 15, 2026.
Third-quarter sales reached USD 25.40 billion in the period ended September 30, 2026.
Johnson & Johnson stock costs EUR 227.08 at Lang & Schwarz on October 19, 2026 at 3:32 p.m. CEST, minus 0.51 percent versus the Xetra close of October 16, 2026.
Johnson & Johnson declared a USD 1.34 dividend per share payable on December 8, 2026.

Soft watercolor painting of a city skyline across a calm misty river, a riverside park path in the foreground with a bench and lamp post under mature green trees, pastel blue sky, muted terracotta building facades reflected in the still water — Johnson stammt aus New Brunswick, US4781601046 Aquarell zeigt Skyline mit Fluss und Park, Illustration mit AI erstellt.

Bernstein lifted its Johnson & Johnson target from USD 261 to USD 270 on October 15, 2026, according to Investing.com. The new target is 5.87 percent above the NYSE price of USD 255.02 on October 19, 2026 at 3:37 p.m. CEST. Johnson & Johnson stock was trading at EUR 227.08 at Lang & Schwarz on October 19, 2026 at 3:32 p.m. CEST, minus 0.51 percent versus the Xetra close of October 16, 2026 at EUR 228.25.

Third-quarter sales set the base

Johnson & Johnson reported third-quarter sales of USD 25.40 billion, up 5.9 percent from USD 23.99 billion in the third quarter of 2025, in its October 13, 2026 release. The company also lifted adjusted earnings per share guidance for fiscal year 2026 to USD 11.05-11.15, with a midpoint of USD 11.10, according to Johnson & Johnson. The release identified a one-time special charge behind third-quarter GAAP earnings per share of USD 0.09, while adjusted earnings per share came to USD 2.59.

Price position on October 19

The euro quote had a bid of EUR 226.85 and an ask of EUR 227.30 at 3:32 p.m. CEST. The same-day JNJ.DE quote showed a range of EUR 225.55 to EUR 227.95 at 3:06 p.m. CEST. The 52-week range was EUR 158.56 to EUR 242.00, leaving the price 6.17 percent below the high.

Valuation and the next cash date

Johnson & Johnson had a market capitalization of USD 614.6 billion, a P/E ratio of 38.64 and a dividend yield of 2.00 percent on October 19, 2026. The company declared a fourth-quarter dividend of USD 1.34 per share, payable on December 8, 2026, to shareholders of record on November 24, 2026, as reported by RTTNews.

Comparison with peers

Johnson & Johnson (NYSE, USD): minus 0.21 percent, P/E 38.64, market capitalization USD 614.6 billion

Pfizer (NYSE, USD): plus 0.12 percent, P/E 39.16, market capitalization USD 168.8 billion

Merck KGaA (Xetra, EUR): minus 1.14 percent, P/E 26.17, market capitalization EUR 62.0 billion

Where the stock stands

The analyst target, quarterly growth and dividend point to three separate reference points for the stock. The euro quote remains below its Xetra close, while the home-market price is also lower on the session.

Johnson & Johnson was trading at EUR 227.08 at Lang & Schwarz on October 19, 2026 at 3:32 p.m. CEST, minus 0.51 percent versus the Xetra close of October 16, 2026 at EUR 228.25. The further course of trading is shown by the continuously updated real-time quote of Johnson & Johnson stock.